All-<i>trans</i>-Retinoic Acid in Acute Promyelocytic Leukemia
Martin S. Tallman(Memorial Sloan Kettering Cancer Center), Peter H. Wiernik(Albert Einstein College of Medicine), Angela Ogden(Children's Cancer Center), Charles A. Schiffer(Veterans Health Administration), Frederick R. Appelbaum(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Cheryl L. Willman(Mayo Clinic), Clara D. Bloomfield(North Shore University Hospital), Jacob M. Rowe(City Of Hope National Medical Center), Janet W. Andersen(Dana-Farber Cancer Institute), James H. Feusner(UCSF Benioff Children's Hospital), Lois E. Shepherd(Ontario Institute for Cancer Research)
Cited by 1,093
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k